fluorodeoxyglucose f18 has been researched along with Frontotemporal Lobar Degeneration in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.57) | 29.6817 |
2010's | 22 (78.57) | 24.3611 |
2020's | 5 (17.86) | 2.80 |
Authors | Studies |
---|---|
Diehl-Schmid, J; Grimmer, T; Hedderich, DM; Jiang, J; Lizarraga, A; Navab, N; Rominger, A; Schultz, T; Schutte, M; Shi, K; Wang, M; Yakushev, I; Yan, Z; Ziegler, S | 1 |
Ai, L; Cai, L; Chen, Y; Cui, R; Gan, J; Guan, YH; Ji, Y; Liu, S; Shi, Z; Zhang, N; Zhao, X; Zuo, C | 1 |
Belho, E; Gupta, V; Mahajan, H; Ranjan, R; Seniaray, N; Verma, R | 1 |
Baker, SL; Boxer, A; DeCarli, C; Edwards, L; Gorno-Tempini, M; Grinberg, LT; Hepker, M; Huang, E; Hwang, JL; Iaccarino, L; Jagust, WJ; Janabi, M; La Joie, R; Lesman-Segev, OH; Lobach, I; Miller, BL; Olichney, J; Pham, J; Rabinovici, GD; Rosen, HJ; Seeley, WW; Seo, SW; Spina, S | 1 |
Baker, MC; Bigio, EH; Buciuc, M; Dickson, DW; Duffy, JR; Flanagan, ME; Franczak, MB; Ghetti, BF; Graff-Radford, J; Graff-Radford, NR; Josephs, KA; Kasanuki, K; Lowe, VJ; Machulda, MM; Parisi, JE; Rademakers, R; Raghunathan, A; Reichard, RR; Ross, OA; Rush, BK; Strand, EA; Whitwell, JL | 1 |
Evren Erdener, S; Onder, H; Saka, E | 1 |
Anderl-Straub, S; Beer, A; Danek, A; Diehl-Schmid, J; Drzezga, A; Edbauer, D; Fassbender, K; Fliessbach, K; Förstl, H; Goldhardt, O; Grimmer, T; Kornhuber, J; Krause, BJ; Landwehrmeyer, GB; Lauer, M; Levin, J; Licata, A; Ludolph, AC; Lyros, E; Otto, M; Prudlo, J; Schroeter, ML; Spottke, A; Volk, A; Yakushew, I | 1 |
Innis, RB; Jenko, KJ; Kim, MJ; Kreisl, WC; McGwier, M; Morse, C; Pike, VW; Snow, J; Zoghbi, SS | 1 |
Barthel, H; Diehl-Schmid, J; Draganski, B; Drzezga, A; Dukart, J; Fellgiebel, A; Förster, S; Frackowiak, R; Kurz, A; Müller, K; Obrig, H; Perneczky, R; Sabri, O; Santarnecchi, E; Schroeter, ML; Yakushev, I | 1 |
Barthel, H; Becker, G; Dukart, J; Frisch, S; Horstmann, A; Müller, K; Sabri, O; Schroeter, ML; Villringer, A; Vogt, B | 1 |
Bode, M; Hänninen, T; Kaivorinne, AL; Moilanen, V; Remes, AM; Suhonen, NM; Takalo, R | 1 |
Abbate, C; Arosio, B; Chiara, LR; Deriz, M; Fenoglio, C; Ferri, E; Galimberti, D; Gussago, C; Mari, D; Nicolini, P; Rossi, PD; Scarpini, E; Serpente, M | 1 |
Bugiani, O; Ferretti, MG; Lerza, MC; Puoti, G; Rossi, G; Tagliavini, F | 1 |
Diehl-Schmid, J; Drzezga, A; Gruppe, T; Kuhn, J; Onur, OA | 1 |
Caminiti, SP; Cappa, SF; Cerami, C; Comi, G; Coppi, E; Falini, A; Ferrari, L; Gianolli, L; Iannaccone, S; Magnani, G; Passerini, G; Perani, D; Pinto, P; Santangelo, R | 1 |
Benali, H; Bertin, H; Brice, A; Caroppo, P; Colliot, O; Corvol, JC; Deramecourt, V; Didic, M; Dubois, B; Durrleman, S; Edouart, G; Funkiewiez, A; Gaubert, M; Habert, MO; Hahn, V; Hannequin, D; Le Ber, I; Lehericy, S; Lejeune, P; Pasquier, F; Perlbarg, V; Rivaud-Pechoux, S; Routier, A; Valabregue, R; Vercelletto, M | 1 |
Diehl-Schmid, J; Drzezga, A; Förster, S; Grimmer, T; Meng, C; Riedl, V; Shao, J; Sorg, C; Tahmasian, M; Yousefi, BH | 1 |
Diehl-Schmid, J; Drzezga, A; Grimmer, T; Li, J; Perneczky, R; Shi, K; Titov, D; Yakushev, I; Zou, N | 1 |
Buhour, MS; de La Sayette, V; Desgranges, B; Doidy, F; Eustache, F; Laisney, M; Pitel, AL; Viader, F | 1 |
Barthel, H; Becker, G; Dukart, J; Frisch, S; Horstmann, A; Möller, HE; Mueller, K; Sabri, O; Schroeter, ML; Villringer, A; Vogt, B | 1 |
Chin, J; Go, SM; Jeong, JH; Kim, SH; Na, DL; Seo, SW; Suh, MK | 1 |
Barthel, H; Becker, G; Frisch, S; Heiner, S; Marschhauser, A; Raczka, KA; Sabri, O; Scheid, R; Schroeter, ML; Seese, A | 1 |
Aizenstein, HJ; Arnold, SE; Barbas, NR; Boeve, BF; Burke, JR; Clark, CM; DeCarli, CS; DeKosky, ST; Diaz-Arrastia, R; Farlow, MR; Foster, NL; Gabel, MJ; Heidebrink, JL; Higdon, R; Jagust, WJ; Kawas, CH; Koeppe, RA; Leverenz, JB; Lipton, AM; Peskind, ER; Turner, RS; Womack, KB; Zamrini, EY | 1 |
Hajak, G; Hirschberger, B; Ibach, B; Klünemann, H; Männer, P; Marienhagen, J; Poljansky, S | 1 |
Acosta-Cabronero, J; Fryer, TD; Hodges, JR; Nestor, PJ; Patterson, K; Pengas, G; Williams, GB | 1 |
Agarwal, N; Alkalay, A; Dearmond, SJ; Furst, AJ; Gorno-Tempini, ML; Grinberg, LT; Growdon, ME; Huang, EJ; Jagust, WJ; Janabi, M; Jang, JY; Karydas, A; Kornak, J; Miller, BL; Mormino, EC; O'Neil, JP; Rabinovici, GD; Rosen, HJ; Seeley, WW; Trojanowski, JQ | 1 |
Black, SE; Chow, TW; Fam, D; Graff-Guerrero, A; Houle, S; Masellis, M; Pollock, BG; Tang-Wai, DF; Verhoeff, NP; Wilson, AA | 1 |
Chin, J; Jung, DS; Kim, BC; Kim, EJ; Kim, SJ; Lee, KH; Na, DL; Sin, JS; Yoon, YJ | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Frontotemporal Lobar Degeneration
Article | Year |
---|---|
Imaging frontotemporal lobar degeneration.
Topics: Brain; C9orf72 Protein; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Intercellular Signaling Peptides and Proteins; Mutation; Neuroimaging; Progranulins; Proteins; Radiography; Radionuclide Imaging; tau Proteins | 2014 |
27 other study(ies) available for fluorodeoxyglucose f18 and Frontotemporal Lobar Degeneration
Article | Year |
---|---|
Reducing instability of inter-subject covariance of FDG uptake networks using structure-weighted sparse estimation approach.
Topics: Alzheimer Disease; Brain; Brain Mapping; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies | 2022 |
Analysis of positron emission tomography hypometabolic patterns and neuropsychiatric symptoms in patients with dementia syndromes.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Positron-Emission Tomography; Syndrome | 2023 |
Spectrum of Frontotemporal Lobar Degeneration on 18F-FDG PET/CT Scan.
Topics: Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
Diagnostic Accuracy of Amyloid versus
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Autopsy; Brain; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Pick Disease of the Brain; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; tau Proteins; Thiazoles | 2021 |
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Language Tests; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Progressive anterior operculum syndrome due to frontotemporal lobar degeneration.
Topics: Aged; Deglutition Disorders; Dysarthria; Facial Paralysis; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2018 |
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.
Topics: Aged; C9orf72 Protein; Cerebellum; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Mutation; Positron-Emission Tomography; Sensitivity and Specificity; Thalamus | 2019 |
Neuroinflammation in frontotemporal lobar degeneration revealed by
Topics: Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA | 2019 |
Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET.
Topics: Adult; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Positron-Emission Tomography | 2013 |
Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Glucose; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Positron-Emission Tomography | 2013 |
Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study.
Topics: C9orf72 Protein; Disease Progression; DNA Repeat Expansion; Fluorodeoxyglucose F18; Follow-Up Studies; Frontotemporal Lobar Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proteins | 2015 |
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion: a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits.
Topics: Aged; C9orf72 Protein; DNA Repeat Expansion; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Hypoxia; Male; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Proteins | 2014 |
A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
Topics: 5' Untranslated Regions; Aged; C9orf72 Protein; Cell Line, Transformed; DNA Mutational Analysis; Enzyme-Linked Immunosorbent Assay; Family Health; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Genotype; Humans; Intercellular Signaling Peptides and Proteins; Italy; Lymphocytes; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Phenotype; Positron-Emission Tomography; Progranulins; Proteins; RNA, Messenger | 2014 |
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; tau Proteins | 2016 |
Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
Topics: Adult; Asymptomatic Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Frontotemporal Lobar Degeneration; Humans; Intercellular Signaling Peptides and Proteins; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mutation; Organ Size; Positron-Emission Tomography; Progranulins; Radiopharmaceuticals; Temporal Lobe | 2015 |
Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Broca; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nerve Net; Neurodegenerative Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results | 2016 |
Metabolic connectivity for differential diagnosis of dementing disorders.
Topics: Aged; Alzheimer Disease; Brain Mapping; Case-Control Studies; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Metabolic Networks and Pathways; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2017 |
Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.
Topics: Aged; Atrophy; Biological Variation, Individual; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
Topics: Age Factors; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cerebellum; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Glucose; Humans; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Signal Processing, Computer-Assisted | 2010 |
Semantic dementia combined with motor neuron disease.
Topics: Brain; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motor Neuron Disease; Positron-Emission Tomography | 2009 |
Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - a pilot FDG-PET study.
Topics: Aged; Behavioral Symptoms; Brain Mapping; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Pilot Projects; Positron-Emission Tomography; Statistics as Topic | 2010 |
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
Topics: Adult; Age of Onset; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Temporal Lobe | 2011 |
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.
Topics: Aged; Aging; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Cerebrospinal Fluid Proteins; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story.
Topics: Aged; Atrophy; Brain Mapping; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Imaging, Three-Dimensional; Male; Metabolic Diseases; Middle Aged; Nerve Fibers, Myelinated; Neural Pathways; Neuropsychological Tests; Positron-Emission Tomography; Statistics, Nonparametric | 2011 |
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography | 2011 |
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study.
Topics: Antiparkinson Agents; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Memantine; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2013 |
Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR.
Topics: Age of Onset; Aged; Brain Chemistry; Brain Mapping; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2012 |